# CART Therapy in Digestive System Tumors

> **NCT04780529** · NA · UNKNOWN · sponsor: **Innovative Cellular Therapeutics Co., Ltd.** · enrollment: 20 (estimated)

## Conditions studied

- Malignant Neoplasms of Digestive Organs

## Interventions

- **BIOLOGICAL:** gucy2c cart cells

## Key facts

- **NCT ID:** NCT04780529
- **Lead sponsor:** Innovative Cellular Therapeutics Co., Ltd.
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-03
- **Primary completion:** 2022-04
- **Final completion:** 2026-03
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2021-03-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04780529

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04780529, "CART Therapy in Digestive System Tumors". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04780529. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*